v3.21.2
OTHER CURRENT LIABILITIES (Tables)
 9 Months Ended
Sep. 30, 2021
Other Liabilities Disclosure [Abstract]  
Schedule of Other Current Liabilities
Other current liabilities consist of the following:
(US$ in millions)September 30,
2021		December 31,
2020
Unrealized losses on derivative contracts, at fair value$2,277 $3,226 
Accrued liabilities721 652 
Advances on sales (1)
276 406 
Payables for purchase of shares (2)
— 149 
Income tax payable211 55 
Other337 352 
Total$3,822 $4,840 
(1)    The Company records Advances on sales when cash payments are received, or invoices are issued in advance of the Company’s performance, and recognizes revenue once the related performance obligation is completed. Advances on sales is impacted by the seasonality of our business, including the timing of harvests in the northern and southern hemispheres, and amounts at each balance sheet date will generally be recognized in earnings within twelve months or less.
(2)    On December 9, 2020, Bunge filed an unconditional tender offer to acquire all of the shares Bunge did not own in Z.T. Kruszwica S.A. Accordingly, the Company recognized a liability for the fair value of the publicly listed shares not owned at December 31, 2020. The tender offer process was completed in the first quarter of 2021.